• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers

Explore
More

  • Locations
  • Our Story
  • Our Ecosystem
  • Our Team
  • Culture of Expedition
  • Careers
Home/About/Our Team

Our Team

Our team of world-class scientists, builders and operators use their deep industry expertise to power the creation of life-transforming cell and gene therapies.

// About ElevateBio

Meet Our Team of Industry Experts

Jacob Abrams

General Counsel

Read Bio

LinkedIn

Bhakti Bhargava, MBA

Chief Financial Officer

Read Bio

LinkedIn

Catherine Hu

SVP, Corporate Affairs & Investor Relations

Read Bio

LinkedIn

Katie Jorgensen

VP, Site Head, BaseCamp

Read Bio

LinkedIn

Tess Kitchener

VP, BaseCamp BD Manufacturing

Read Bio

LinkedIn

Missy Kotchey

SVP, Head of People & Culture

Read Bio

LinkedIn

Aaron Nudelman, Ph.D., J.D.

SVP, Head of Intellectual Property

Read Bio

LinkedIn

Michael Paglia, M.S.

Chief Technology Officer of BaseCamp

Read Bio

LinkedIn

Amy Pooler, Ph.D.

SVP, Research and Development of Life Edit

Read Bio

LinkedIn

Heidi Wagner, J.D.

Global Head of Government Affairs

Read Bio

LinkedIn

Board of Directors

We are advised and supported by a team of world-class technology and biotechnology industry experts with unmatched track records in building iconic companies and creating value in the field of rare disease and cell and gene therapy.

David Hallal

CEO of Scholar Rock and Executive Chairman, ElevateBio

Vikas Sinha

CFO of Scholar Rock

Ansbert Gadicke

Co-founder of MPM Capital

Morana Jovan-Embiricos, Ph.D.

Managing Partner of F2 Ventures

Germano Giuliani

Former CEO, Giuliani Pharma; Board of Directors, HBM Healthcare AH; Investment Committee Royalty Pharma

Khalil Barrage

Managing Director of The Invus Group

Karan Takhar

Managing Director, Matrix Capital Management Company

Navneet Govil

Managing Partner, SoftBank

Our Company’s Co‑Founders

We were founded in 2017 by three industry leaders who asked the question: what could revolutionize medicine in the next 50 years?

David Hallal

Executive Chairman, ElevateBio Board of Directors

Read Bio

LinkedIn

Mitchell H. Finer, Ph.D.

Strategic Advisor

Read Bio

LinkedIn

Vikas Sinha, MBA

Member, Board of Directors and Chair of the Audit Committee

Read Bio

LinkedIn

Investors

Committed to enabling innovative cell and gene therapy companies

EcoR1 Capital
edbi
Emerson Collective
Fidelity Investment
Invus
Itochu
Matrix Capital Management
MPM
Redmile Group
Samsara Biocapital
SoftBank
Surveyor
F2 Ventures
Woodline Partners

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact
MENU
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact